Despite testing for CRP level is used in clinical practice, due to the fact that the test is widely available, the US Preventive Services Task Force (USPSTF) recommendation on using nontraditional risk factors in CHD risk assessment concluded that the current evidence is insufficient to assess the balance of benefits and harms of using the CRP level in risk assessment for CVD in asymptomatic adults to prevent CVD events [43]. Here, CRP is linked to coronary artery disorder.